NAGE — Niagen Bioscience, Inc. · P/E 59, rev $61.3M

Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.

Latest reported NAGE revenue for 2026-06-30 was $61.3M. Net income was $7.3M. Revenue was up 94.6% from 2026-03-31 to 2026-06-30. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.

Use this NAGE page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the NAGE quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the NAGE SEC filings page. Lician reads the product cache first so this HTML stays unique to Niagen Bioscience, Inc. even when a live quote feed is slow.